Literature DB >> 31102028

Cognitive Assessment of Individuals with Multiple Sclerosis in the Arab World: a Systematic Review.

Samira Paul1,2, Aeysha Brown1,2, Abbey J Hughes3.   

Abstract

The prevalence of multiple sclerosis (MS) is on the rise globally, and recent epidemiological studies have observed increased rates in the Arab world (i.e., countries of North Africa and the Middle East where Arabic is the primary language). However, assessment of cognitive impairment and its relevant covariates (e.g., fatigue and depressive symptomatology) in the Arab world has not been rigorously reviewed. Thus, the objective of the present study was to systematically review the current use of cognitive assessment measures in observational and interventional studies of individuals with MS in the Arab world. A systematic review of studies that assessed cognitive function in adults with MS in the Arab world was conducted using PubMed, PsycINFO, CINAHL, The Cochrane Library, Embase, WHO Global Index Medicus, and Ovid Global Health. Studies that featured at least one objective cognitive measure were included. Eligible studies were reviewed for bias and study quality using the QUADAS-2 and NIH QAT. Study characteristics and finding were extracted by two independent reviewers, with results confirmed by a third reviewer. A total of 13 (N = 846) studies met inclusion criteria. Risk of bias and included measures varied across studies. Results demonstrated inconsistent availability and use of MS cognitive assessment tools across the Arab world. An Arabic version of the BICAMS was the only cognitive battery that was evaluated with regard to psychometric properties. The most common individual test include in reviewed studies was the SDMT. However, validation studies are still needed for this and a number of other measures. Other measures are still in the early stages of translation and cultural-linguistic norming. This review of cognitive assessment of individuals with MS in the Arab world was limited by variable study quality and measure selection. The present review provides a summary of the tests most commonly used in this region and recommendations for future investigation.

Entities:  

Keywords:  Arabic; Cognitive assessment; Multiple sclerosis

Year:  2019        PMID: 31102028     DOI: 10.1007/s11065-019-09408-5

Source DB:  PubMed          Journal:  Neuropsychol Rev        ISSN: 1040-7308            Impact factor:   7.444


  43 in total

1.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.

Authors:  David Moher; Alessandro Liberati; Jennifer Tetzlaff; Douglas G Altman
Journal:  Ann Intern Med       Date:  2009-07-20       Impact factor: 25.391

2.  Clinical characteristics of multiple sclerosis in Lebanon.

Authors:  B Yamout; W Barada; R A Tohme; A Mehio-Sibai; R Khalifeh; T El-Hajj
Journal:  J Neurol Sci       Date:  2008-03-25       Impact factor: 3.181

3.  Predictors of quality of life among multiple sclerosis patients: a comprehensive analysis.

Authors:  B Yamout; Z Issa; A Herlopian; M El Bejjani; A Khalifa; A S Ghadieh; R H Habib
Journal:  Eur J Neurol       Date:  2013-01-08       Impact factor: 6.089

4.  Validity of the minimal assessment of cognitive function in multiple sclerosis (MACFIMS).

Authors:  Ralph H B Benedict; Diane Cookfair; Rebecca Gavett; Mark Gunther; Frederick Munschauer; Neeta Garg; Bianca Weinstock-Guttman
Journal:  J Int Neuropsychol Soc       Date:  2006-07       Impact factor: 2.892

5.  The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus.

Authors:  L B Krupp; N G LaRocca; J Muir-Nash; A D Steinberg
Journal:  Arch Neurol       Date:  1989-10

Review 6.  Multiple Sclerosis Epidemiology in Middle East and North Africa: A Systematic Review and Meta-Analysis.

Authors:  Pouria Heydarpour; Shayan Khoshkish; Shabnam Abtahi; Maziar Moradi-Lakeh; Mohammad Ali Sahraian
Journal:  Neuroepidemiology       Date:  2015-06-16       Impact factor: 3.282

7.  A new assessment tool for patients with multiple sclerosis from Spanish-speaking countries: validation of the Brief International Cognitive Assessment for MS (BICAMS) in Argentina.

Authors:  Sandra Vanotti; Audrey Smerbeck; Ralph H B Benedict; Fernando Caceres
Journal:  Clin Neuropsychol       Date:  2016-05-12       Impact factor: 3.535

Review 8.  Cognitive impairment in multiple sclerosis.

Authors:  Nancy D Chiaravalloti; John DeLuca
Journal:  Lancet Neurol       Date:  2008-12       Impact factor: 44.182

9.  QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies.

Authors:  Penny F Whiting; Anne W S Rutjes; Marie E Westwood; Susan Mallett; Jonathan J Deeks; Johannes B Reitsma; Mariska M G Leeflang; Jonathan A C Sterne; Patrick M M Bossuyt
Journal:  Ann Intern Med       Date:  2011-10-18       Impact factor: 25.391

Review 10.  Recommendations for cognitive screening and management in multiple sclerosis care.

Authors:  Rosalind Kalb; Meghan Beier; Ralph Hb Benedict; Leigh Charvet; Kathleen Costello; Anthony Feinstein; Jeffrey Gingold; Yael Goverover; June Halper; Colleen Harris; Lori Kostich; Lauren Krupp; Ellen Lathi; Nicholas LaRocca; Ben Thrower; John DeLuca
Journal:  Mult Scler       Date:  2018-10-10       Impact factor: 6.312

View more
  1 in total

1.  Rising prevalence of multiple sclerosis in Saudi Arabia, a descriptive study.

Authors:  Mohammed AlJumah; R Bunyan; H Al Otaibi; G Al Towaijri; A Karim; Y Al Malik; M Kalakatawi; S Alrajeh; M Al Mejally; H Algahtani; A Almubarak; E Cupler; S Alawi; S Qureshi; S Nahrir; A Almalki; A Alhazzani; I Althubaiti; N Alzahrani; E Mohamednour; J Saeedi; S Ishak; H Almudaiheem; A El-Metwally; A Al-Jedai
Journal:  BMC Neurol       Date:  2020-02-08       Impact factor: 2.474

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.